Country: Sweden
Language: Swedish
Source: Läkemedelsverket (Medical Products Agency)
influensavirus A/California/7/2009 (H1N1)-deriverad stam (NYMC X-181), spjälkat virus, inaktiverat; influensavirus A/Perth/16/2009 (H3N2)-liknande stam (NYMC X-187, deriverad från A/Victoria/210/2009), spjälkat virus, inaktiverat; influensavirus B/Brisbane/60/2008-liknande stam (B/Brisbane/60/2008), ytantigen, inaktiverat
Abbott Biologicals B.V.
J07BB02
the influenza virus A/California/7/2009 (H1N1)-derived strain (NYMC X-181), spjälkat virus, inactivated; influenza virus, A/Perth/16/2009 (H3N2)-like strain (NYMC X-187, derived from A/Victoria/210/2009), spjälkat virus, inactivated; influenza virus, B/Brisbane/60/2008-like strain (B/Brisbane/60/2008), the surface antigen, inactivated
Injektionsvätska, suspension, förfylld spruta
influensavirus A/California/7/2009 (H1N1)-deriverad stam (NYMC X-181), spjälkat virus, inaktiverat 15 mikrog Aktiv substans; influensavirus B/Brisbane/60/2008-liknande stam (B/Brisbane/60/2008), ytantigen, inaktiverat 15 mikrog Aktiv substans; influensavirus A/Perth/16/2009 (H3N2)-liknande stam (NYMC X-187, deriverad från A/Victoria/210/2009), spjälkat virus, inaktiverat 15 mikrog Aktiv substans
Receptbelagt
spjälkat virus eller ytantigen
Avregistrerad
2000-06-30